These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30192770)

  • 1. Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania.
    Gallay J; Pothin E; Mosha D; Lutahakana E; Mazuguni F; Zuakulu M; Decosterd LA; Genton B
    PLoS One; 2018; 13(9):e0202745. PubMed ID: 30192770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance.
    Hodel EM; Kabanywanyi AM; Malila A; Zanolari B; Mercier T; Beck HP; Buclin T; Olliaro P; Decosterd LA; Genton B
    PLoS One; 2009 Dec; 4(12):e8184. PubMed ID: 20011529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of malaria diagnosis and treatment for fever episodes according to patient history and anti-malarial blood measurement: a cross-sectional survey from Tanzania.
    Gallay J; Mosha D; Lutahakana E; Mazuguni F; Zuakulu M; Decosterd LA; Genton B; Pothin E
    Malar J; 2018 May; 17(1):209. PubMed ID: 29784001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do health workers' preferences influence their practices? Assessment of providers' attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania.
    Masanja IM; Lutambi AM; Khatib RA
    BMC Public Health; 2012 Nov; 12():956. PubMed ID: 23137196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
    Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
    Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?
    Kamugisha E; Bujila I; Lahdo M; Pello-Esso S; Minde M; Kongola G; Naiwumbwe H; Kiwuwa S; Kaddumukasa M; Kironde F; Swedberg G
    Acta Trop; 2012 Feb; 121(2):148-51. PubMed ID: 22118982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
    Ndeserua R; Juma A; Mosha D; Chilongola J
    Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
    Tarimo DS; Malekela DA
    East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Testing and Prompt Use of Recommended Antimalarials following Malaria Diagnosis: A Secondary Analysis of 2011-12 Tanzania HIV and Malaria Indicator Survey Data.
    Adinan J; Damian DJ; Msuya SE
    PLoS One; 2015; 10(7):e0132964. PubMed ID: 26186547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma.
    Hodel EM; Zanolari B; Mercier T; Biollaz J; Keiser J; Olliaro P; Genton B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):867-86. PubMed ID: 19249251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania.
    Bruxvoort K; Kalolella A; Nchimbi H; Festo C; Taylor M; Thomson R; Cairns M; Thwing J; Kleinschmidt I; Goodman C; Kachur SP
    Trop Med Int Health; 2013 Oct; 18(10):1269-82. PubMed ID: 23937722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study.
    Ndong IC; Reenen Mv; Boakye DA; Mbacham WF; Grobler AF
    Acta Trop; 2015 Oct; 150():100-6. PubMed ID: 26095044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.
    Pearce RJ; Ord R; Kaur H; Lupala C; Schellenberg J; Shirima K; Manzi F; Alonso P; Tanner M; Mshinda H; Roper C; Schellenberg D
    J Infect Dis; 2013 Mar; 207(5):848-59. PubMed ID: 23225897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.